Sun Pharmaceuticals Industries (BOM:524715) Other Current Liabilities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524715 Sun Pharmaceuticals Industries Ltd BOM:524715
89 GF Score
Price ₹1,920.10
GF Value ₹1,960.10
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Sun Pharmaceuticals Industries Other Current Liabilities?

Sun Pharmaceuticals Industries BOM:524715 +1.03% 89 Other Current Liabilities is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:524715 with a GF Score™ of 89/100 and a GF Value™ of ₹1,960.10 (Fairly Valued). The stock has 2 warning signs investors should review.

Sun Pharmaceuticals Industries's other current liabilities for the quarter that ended in Jun. 2026 was ₹0 Mil.

Sun Pharmaceuticals Industries's quarterly other current liabilities increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹90,147 Mil) but then declined from Mar. 2026 (₹90,147 Mil) to Jun. 2026 (₹0 Mil).

Sun Pharmaceuticals Industries's annual other current liabilities increased from Mar. 2024 (₹69,801 Mil) to Mar. 2025 (₹81,505 Mil) and increased from Mar. 2025 (₹81,505 Mil) to Mar. 2026 (₹90,147 Mil).

Sun Pharmaceuticals Industries Other Current Liabilities Related Terms

Sun Pharmaceuticals Industries Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Sun Pharmaceuticals Industries's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharmaceuticals Industries Other Current Liabilities Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 100,684.20 65,421.30 69,801.30 81,505.10 90,147.10

Sun Pharmaceuticals Industries Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 118,565.00 0.00 90,147.10 0.00
BOM:524715
89GF Score
Sun Pharmaceuticals Industries Ltd BOM:524715
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sun Pharmaceuticals Industries Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ₹0 Mil mean?
Sun Pharmaceuticals Industries (BOM:524715) has a Other Current Liabilities of ₹0 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Sun Pharmaceuticals Industries.
Is Sun Pharmaceuticals Industries' Other Current Liabilities too high?
Sun Pharmaceuticals Industries' current Other Current Liabilities is ₹0 Mil. Overall, Sun Pharmaceuticals Industries has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sun Pharmaceuticals Industries' Other Current Liabilities compare to ZTS and UTHR?
Sun Pharmaceuticals Industries' Other Current Liabilities of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Sun Pharmaceuticals Industries. Sun Pharmaceuticals Industries's current Other Current Liabilities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharmaceuticals Industries stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharmaceuticals Industries (BOM:524715) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,960.10, compared to a current price of ₹1,920.10 — trading 2% below its estimated fair value. The current Other Current Liabilities is ₹0 Mil. Sun Pharmaceuticals Industries' overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Sun Pharmaceuticals Industries (BOM:524715), the current Other Current Liabilities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sun Pharmaceuticals Industries (BOM:524715) Overvalued in 2026?

Based on GuruFocus' analysis, Sun Pharmaceuticals Industries stock appears to be undervalued. The current stock price of ₹1,920.10 is trading 2% below its estimated GF Value™ of ₹1,960.10. GuruFocus considers Sun Pharmaceuticals Industries to be Fairly Valued.

Key valuation signals for BOM:524715:

  • Other Current Liabilities: ₹0 Mil
  • GF Value™: ₹1,960.10 vs. price of ₹1,920.10 (2% below fair value)
  • GF Score™: 89/100 with 2 warning signs

No single metric tells the full story. See the BOM:524715 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sun Pharmaceuticals Industries Business Description

Other Exchanges SUNPHARMA:India
Address Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.
89GF Score

Get the complete analysis for BOM:524715

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,920.10
Price
₹1,960.10
GF Value